An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Authors
Keywords
-
Journal
CELL
Volume 184, Issue 13, Pages 3452-3466.e18
Publisher
Elsevier BV
Online
2021-05-25
DOI
10.1016/j.cell.2021.05.032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elucidation of Interactions Regulating Conformational Stability and Dynamics of SARS-CoV-2 S-Protein
- (2021) Takaharu Mori et al. BIOPHYSICAL JOURNAL
- Neutralizing antibody titres in SARS-CoV-2 infections
- (2021) Eric H. Y. Lau et al. Nature Communications
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
- (2021) Elizabeth M. Anderson et al. CELL
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
- (2020) Wei Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear
- (2020) Nathan D. Grubaugh et al. CELL
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike
- (2020) Susmita Roy et al. Journal of Physical Chemistry Letters
- Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein
- (2020) Marc C. Johnson et al. JOURNAL OF VIROLOGY
- Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
- (2020) Sakiko Tabata et al. LANCET INFECTIOUS DISEASES
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
- (2020) Seth J. Zost et al. NATURE MEDICINE
- Controlling the SARS-CoV-2 spike glycoprotein conformation
- (2020) Rory Henderson et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
- (2020) Zhe Lv et al. SCIENCE
- Distinct conformational states of SARS-CoV-2 spike protein
- (2020) Yongfei Cai et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
- (2020) Leonid Yurkovetskiy et al. CELL
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
- (2020) Sean T. H. Liu et al. NATURE MEDICINE
- In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges
- (2020) Beata Turoňová et al. SCIENCE
- Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution
- (2020) Dianita S. Saputri et al. Frontiers in Microbiology
- Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles
- (2020) Maolin Lu et al. Cell Host & Microbe
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors
- (2017) Fumiji Saito et al. NATURE
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
- (2017) Ali Punjani et al. NATURE METHODS
- IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
- (2017) Taia T. Wang et al. SCIENCE
- Microbially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2
- (2016) Kouyuki Hirayasu et al. Nature Microbiology
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway
- (2011) M. Jaume et al. JOURNAL OF VIROLOGY
- PILRα Is a Herpes Simplex Virus-1 Entry Coreceptor That Associates with Glycoprotein B
- (2008) Takeshi Satoh et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search